Published in Am J Obstet Gynecol on July 15, 1975
A ten-minute DNA preparation from yeast efficiently releases autonomous plasmids for transformation of Escherichia coli. Gene (1987) 25.43
Yeast Gcn5 functions in two multisubunit complexes to acetylate nucleosomal histones: characterization of an Ada complex and the SAGA (Spt/Ada) complex. Genes Dev (1997) 8.35
DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs. Genes Dev (1998) 6.96
Histone H3 lysine 4 methylation is mediated by Set1 and required for cell growth and rDNA silencing in Saccharomyces cerevisiae. Genes Dev (2001) 6.28
Eviction and transplacement of mutant genes in yeast. Methods Enzymol (1983) 5.71
Mutations affecting Ty-mediated expression of the HIS4 gene of Saccharomyces cerevisiae. Genetics (1984) 5.64
Identification of a Ty insertion within the coding sequence of the S. cerevisiae URA3 gene. Mol Gen Genet (1984) 5.44
Evidence that SNF2/SWI2 and SNF5 activate transcription in yeast by altering chromatin structure. Genes Dev (1992) 5.38
Evidence that Spt4, Spt5, and Spt6 control transcription elongation by RNA polymerase II in Saccharomyces cerevisiae. Genes Dev (1998) 5.16
Whole-genome expression analysis of snf/swi mutants of Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (2000) 4.54
The SPT3 gene is required for normal transcription of Ty elements in S. cerevisiae. Cell (1984) 4.07
Functional organization of the yeast SAGA complex: distinct components involved in structural integrity, nucleosome acetylation, and TATA-binding protein interaction. Mol Cell Biol (1999) 3.90
Changes in histone gene dosage alter transcription in yeast. Genes Dev (1988) 3.74
The bromodomain: a conserved sequence found in human, Drosophila and yeast proteins. Nucleic Acids Res (1992) 3.57
The S. cerevisiae SAGA complex functions in vivo as a coactivator for transcriptional activation by Gal4. Genes Dev (2001) 3.54
Essential functional interactions of SAGA, a Saccharomyces cerevisiae complex of Spt, Ada, and Gcn5 proteins, with the Snf/Swi and Srb/mediator complexes. Genetics (1997) 3.45
SPT15, the gene encoding the yeast TATA binding factor TFIID, is required for normal transcription initiation in vivo. Cell (1989) 3.39
SPT3 interacts with TFIID to allow normal transcription in Saccharomyces cerevisiae. Genes Dev (1992) 3.31
Evidence that Spt6p controls chromatin structure by a direct interaction with histones. Science (1996) 3.23
Redundant roles for the TFIID and SAGA complexes in global transcription. Nature (2000) 3.21
The SPT6 gene is essential for growth and is required for delta-mediated transcription in Saccharomyces cerevisiae. Mol Cell Biol (1987) 3.15
The Spt components of SAGA facilitate TBP binding to a promoter at a post-activator-binding step in vivo. Genes Dev (1999) 3.15
Striking conservation of TFIID in Schizosaccharomyces pombe and Saccharomyces cerevisiae. Nature (1990) 3.03
SPT4, SPT5 and SPT6 interactions: effects on transcription and viability in Saccharomyces cerevisiae. Genetics (1992) 2.92
SPT5, an essential gene important for normal transcription in Saccharomyces cerevisiae, encodes an acidic nuclear protein with a carboxy-terminal repeat. Mol Cell Biol (1991) 2.89
The Swi/Snf family nucleosome-remodeling complexes and transcriptional control. Trends Genet (2000) 2.87
Spt5 and spt6 are associated with active transcription and have characteristics of general elongation factors in D. melanogaster. Genes Dev (2000) 2.78
Two functionally distinct forms of the RSC nucleosome-remodeling complex, containing essential AT hook, BAH, and bromodomains. Mol Cell (1999) 2.76
Ty-mediated gene expression of the LYS2 and HIS4 genes of Saccharomyces cerevisiae is controlled by the same SPT genes. Proc Natl Acad Sci U S A (1984) 2.75
The bromodomain: a chromatin-targeting module? Nat Struct Biol (1999) 2.72
Characterization of amber and ochre suppressors in Salmonella typhimurium. J Bacteriol (1979) 2.68
Mutations that suppress the deletion of an upstream activating sequence in yeast: involvement of a protein kinase and histone H3 in repressing transcription in vivo. Genetics (1993) 2.49
Mutations in SPT16/CDC68 suppress cis- and trans-acting mutations that affect promoter function in Saccharomyces cerevisiae. Mol Cell Biol (1991) 2.38
Three genes are required for trans-activation of Ty transcription in yeast. Genetics (1987) 2.26
A new class of histone H2A mutations in Saccharomyces cerevisiae causes specific transcriptional defects in vivo. Mol Cell Biol (1995) 2.20
Isolation and analysis of a novel class of suppressor of Ty insertion mutations in Saccharomyces cerevisiae. Genetics (1988) 2.20
Glucose repression of transcription of the Schizosaccharomyces pombe fbp1 gene occurs by a cAMP signaling pathway. Genes Dev (1991) 2.12
Transcriptional activation by Gcn4p involves independent interactions with the SWI/SNF complex and the SRB/mediator. Mol Cell (1999) 2.09
The Saccharomyces cerevisiae SPT13/GAL11 gene has both positive and negative regulatory roles in transcription. Mol Cell Biol (1989) 2.09
The Saccharomyces cerevisiae SPT8 gene encodes a very acidic protein that is functionally related to SPT3 and TATA-binding protein. Genetics (1994) 2.04
Evidence that Spt3 functionally interacts with Mot1, TFIIA, and TATA-binding protein to confer promoter-specific transcriptional control in Saccharomyces cerevisiae. Mol Cell Biol (1997) 1.97
SPT20/ADA5 encodes a novel protein functionally related to the TATA-binding protein and important for transcription in Saccharomyces cerevisiae. Mol Cell Biol (1996) 1.89
Two actin-related proteins are shared functional components of the chromatin-remodeling complexes RSC and SWI/SNF. Mol Cell (1998) 1.88
The SNF2, SNF5 and SNF6 genes are required for Ty transcription in Saccharomyces cerevisiae. Genetics (1991) 1.82
SPT6, an essential gene that affects transcription in Saccharomyces cerevisiae, encodes a nuclear protein with an extremely acidic amino terminus. Mol Cell Biol (1990) 1.81
Genetic evidence for promoter competition in Saccharomyces cerevisiae. Mol Cell Biol (1988) 1.75
Isolation and characterization of mutants constitutive for expression of the fbp1 gene of Schizosaccharomyces pombe. Genetics (1990) 1.73
The Saccharomyces cerevisiae SPT7 gene encodes a very acidic protein important for transcription in vivo. Genetics (1995) 1.70
Ty1 transposition in Saccharomyces cerevisiae is nonrandom. Genetics (1989) 1.60
TBP mutants defective in activated transcription in vivo. EMBO J (1995) 1.54
SPT10 and SPT21 are required for transcription of particular histone genes in Saccharomyces cerevisiae. Mol Cell Biol (1994) 1.51
A transcriptionally regulated expression vector for the fission yeast Schizosaccharomyces pombe. Gene (1989) 1.49
Histone H2A is required for normal centromere function in Saccharomyces cerevisiae. EMBO J (2000) 1.45
The products of the SPT10 and SPT21 genes of Saccharomyces cerevisiae increase the amplitude of transcriptional regulation at a large number of unlinked loci. New Biol (1991) 1.41
Analysis of the yeast SPT3 gene and identification of its product, a positive regulator of Ty transcription. Nucleic Acids Res (1986) 1.38
Molecular and genetic characterization of SPT4, a gene important for transcription initiation in Saccharomyces cerevisiae. Mol Gen Genet (1993) 1.38
SPT5, an essential gene important for normal transcription in Saccharomyces cerevisiae, encodes an acidic nuclear protein with a carboxy-terminal repeat. Mol Cell Biol (1991) 1.34
The nucleosome remodeling complex, Snf/Swi, is required for the maintenance of transcription in vivo and is partially redundant with the histone acetyltransferase, Gcn5. EMBO J (1999) 1.33
The SPT10 and SPT21 genes of Saccharomyces cerevisiae. Genetics (1994) 1.25
Letter: Treatment of unipolar depression. Lancet (1975) 1.23
Specific components of the SAGA complex are required for Gcn4- and Gcr1-mediated activation of the his4-912delta promoter in Saccharomyces cerevisiae. Genetics (1999) 1.21
NRG1 is required for glucose repression of the SUC2 and GAL genes of Saccharomyces cerevisiae. BMC Genet (2001) 1.17
Evidence that Snf-Swi controls chromatin structure over both the TATA and UAS regions of the SUC2 promoter in Saccharomyces cerevisiae. Nucleic Acids Res (1997) 1.15
Biochemical and genetic characterization of a yeast TFIID mutant that alters transcription in vivo and DNA binding in vitro. Mol Cell Biol (1992) 1.14
Nucleosomes and transcription: recent lessons from genetics. Curr Opin Genet Dev (1997) 1.14
Identification and analysis of a functional human homolog of the SPT4 gene of Saccharomyces cerevisiae. Mol Cell Biol (1996) 1.13
SPT3 is required for normal levels of a-factor and alpha-factor expression in Saccharomyces cerevisiae. Mol Cell Biol (1988) 1.10
Identification and analysis of Mot3, a zinc finger protein that binds to the retrotransposon Ty long terminal repeat (delta) in Saccharomyces cerevisiae. Mol Cell Biol (1998) 1.08
Characterization of a human homologue of the Saccharomyces cerevisiae transcription factor spt3 (SUPT3H). Genomics (1998) 1.05
A mutant tRNA affects delta-mediated transcription in Saccharomyces cerevisiae. Genetics (1992) 1.00
Equivalent mutations in the two repeats of yeast TATA-binding protein confer distinct TATA recognition specificities. Mol Cell Biol (1994) 0.96
Evidence based advocacy. Inj Prev (2004) 0.93
Pyridoxine and the pill. Lancet (1970) 0.89
Oral contraceptives and depression. Lancet (1969) 0.89
Control of lysogenization by phage P22. I. The P22 cro gene. J Mol Biol (1981) 0.89
Identification and analysis of homologues of Saccharomyces cerevisiae Spt3 suggest conserved functional domains. Yeast (1998) 0.86
Combined antidepressant therapy. Br J Psychiatry (1971) 0.84
Oral contraceptives, pyridoxine, and depression. Am J Psychiatry (1973) 0.84
Oral contraceptives and depression. Lancet (1969) 0.81
Growth and manipulation of yeast. Curr Protoc Mol Biol (2001) 0.80
Control of lysogenization by phage P22. II. Mutations (clyA) in the cl gene that cause increased lysogenization. J Mol Biol (1981) 0.77
Management of a depressive illness. Lancet (1973) 0.75
Antidepressant drugs and excessive weight gain. Br J Psychiatry (1972) 0.75
Compatibility of MAOI and other psychotropic drugs. Br J Psychiatry (1972) 0.75